Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ILMN · against 71 other Healthcare companies of similar size
Ranked #65 of 72 · scores higher than 10% of peers
Bars: peers in each 10-point band of the growth score8 peers with a growth score of 20–29, including ILMN · Click a bar to see the companies
Mainly because of its earnings per share growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | ILMN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 73 reported | 4.9% | 10.0% | 26% | 33% | |
| Earnings per share growthHigher is better · 56 reported | -33.3% | 14.0% | 7% | 33% | |
| 3-year revenue growthHigher is better · 72 reported | 0.2% | 8.2% | 14% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 21.4B USD | 97 | 67 | |
| 2 | 56.7B USD | 96 | 79 | |
| 3 | 22.8B USD | 95 | 38 | |
| 4 | 40.2B USD | 92 | 73 | |
| 5 | 4.61T JPY (≈$31.3B) | 89 | 76 | |
| 61 | 38.9B USD | 36 | 56 | |
| 62 | 64.8B EUR (≈$71.3B) | 29 | 51 | |
| 62 | 18.2B USD | 29 | 40 | |
| 64 | 154.4B BRL (≈$27.8B) | 28 | 43 | |
| 65 | 36.0B USD | 27 | 46 | |
| 66 | 21.7B USD | 26 | 32 | |
| 67 | 16.7B CHF (≈$19.2B) | 24 | 47 | |
| 68 | 36.8B USD | 20 | 46 | |
| 68 | 66.3B USD | 20 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score